Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Desmond J Fitzgerald

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Clinical Pharmacology and Therapeutics|September 15, 2017
Lack of Bioequivalence Among Low-dose, Enteric-coated Aspirin PreparationsDermot Cox, Desmond J Fitzgerald
Thescientificworldjournal|June 14, 2003
Pharmacogenetics of antiplatelet drugsRonan Curtin, Desmond J Fitzgerald
Expert Reviews in Molecular Medicine|February 28, 2004
Cyclooxygenase isoforms and atherosclerosisOrina Belton, Desmond J Fitzgerald
Hematology. American Society of Hematology. Education Program|November 21, 2007
Aspirin and clopidogrel resistanceDesmond J Fitzgerald, Andrew Maree
Seminars in Vascular Medicine|June 17, 2004
Glycoprotein IIb/IIIa antagonists in acute coronary syndromes: where are we now?Andrew Maree, Desmond J Fitzgerald
Proteomics|April 23, 2013
Proteomic identification of the candidate target proteins of 15-deoxy-delta12,14-prostaglandin J2Simone Marcone, Desmond J Fitzgerald
Thrombosis and Haemostasis|December 8, 2004
Aspirin and coronary artery diseaseAndrew O Maree, Desmond J Fitzgerald
Circulation|April 25, 2007
Variable platelet response to aspirin and clopidogrel in atherothrombotic diseaseAndrew O Maree, Desmond J Fitzgerald
Blood|January 11, 2002
A growing set of platelet-activating bacterial proteinsJames P McRedmond, Desmond J Fitzgerald
Circulation Research|January 5, 2013
Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonismDesmond J Fitzgerald, Garret A Fitzgerald
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Clinical Pharmacology and Therapeutics|September 15, 2017
Lack of Bioequivalence Among Low-dose, Enteric-coated Aspirin PreparationsDermot Cox, Desmond J Fitzgerald
Thescientificworldjournal|June 14, 2003
Pharmacogenetics of antiplatelet drugsRonan Curtin, Desmond J Fitzgerald
Expert Reviews in Molecular Medicine|February 28, 2004
Cyclooxygenase isoforms and atherosclerosisOrina Belton, Desmond J Fitzgerald
Hematology. American Society of Hematology. Education Program|November 21, 2007
Aspirin and clopidogrel resistanceDesmond J Fitzgerald, Andrew Maree
Seminars in Vascular Medicine|June 17, 2004
Glycoprotein IIb/IIIa antagonists in acute coronary syndromes: where are we now?Andrew Maree, Desmond J Fitzgerald
Proteomics|April 23, 2013
Proteomic identification of the candidate target proteins of 15-deoxy-delta12,14-prostaglandin J2Simone Marcone, Desmond J Fitzgerald
Thrombosis and Haemostasis|December 8, 2004
Aspirin and coronary artery diseaseAndrew O Maree, Desmond J Fitzgerald
Circulation|April 25, 2007
Variable platelet response to aspirin and clopidogrel in atherothrombotic diseaseAndrew O Maree, Desmond J Fitzgerald
Blood|January 11, 2002
A growing set of platelet-activating bacterial proteinsJames P McRedmond, Desmond J Fitzgerald
Circulation Research|January 5, 2013
Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonismDesmond J Fitzgerald, Garret A Fitzgerald
Pageof 7